For Quick Alerts
ALLOW NOTIFICATIONS  
For Daily Alerts

AstraZeneca Pharma tanks nearly 7% ahead of board meeting on delisting price

By Religare
|
AstraZeneca Pharma tanks nearly 7% ahead of board meeting on delisting price
Shares of drug maker AstraZeneca Pharma India plunged nearly 7 per cent in early trade on Bombay Stock Exchange (BSE) ahead of board meeting today to decide on the delisting price.
 

The decision comes a year after AstraZeneca shelved its plan to go private and instead diluted its stake from 90 per cent to 75 per cent to meet the minimum shareholding limit set by market regulator Sebi, according to ET report.

Weighed down by development, shares of company declined as much as 6.68 per cent to trade at Rs 1156.00 a piece on the BSE.

In a similar fashion, shares of the company slipped 1.26 per cent to Rs 1,225.80 a piece on National Stock Exchange. Meanwhile, the broader benchmark Sensex was quoting at 21,263.94, up 54.21 points or 0.26 per cent at 10:00 hours.

Dion Global Solutions Ltd.

Company Search
We use cookies to ensure that we give you the best experience on our website. This includes cookies from third party social media websites and ad networks. Such third party cookies may track your use on Goodreturns sites for better rendering. Our partners use cookies to ensure we show you advertising that is relevant to you. If you continue without changing your settings, we'll assume that you are happy to receive all cookies on Goodreturns website. However, you can change your cookie settings at any time. Learn more